GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma

Autor: Gallego, S., Bernabeu, D., Garrido-Pontnou, M., Guillen, G., Hindi, N., Juan-Ribelles, A., Marquez, C., Mata, C., Orcajo, J., Ramirez, G., Ramos, M., Romagosa, C., Ruano, D., Rubio, P., Verges, R., Valverde, C., GEIS Grp Espanol Invest Sarcomas, SEHOP Soc Espanola Hematologia Onc

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma (STS) in children and adolescents. In Spain the annual incidence is 4.4 cases per million children < 14 years. It is an uncommon neoplasm in adults, but 40% of RMS are diagnosed in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2d3c5448e1d7904eedc0cdbfd47adec9
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14923